|
Ajanta Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
31701.44 Cr.
|
P/BV
|
8.62
|
Book Value (Rs.)
|
294.36
|
|
52 Week High/Low (Rs.)
|
3485/2111
|
FV/ML
|
2/1
|
P/E(X)
|
34.44
|
|
Bookclosure
|
06/11/2024
|
EPS (Rs.)
|
73.68
|
Div Yield (%)
|
1.10
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4648.10 | 4161.59 | 3707.52 | 3284.13 | 2845.20 |
| Other Operating Revenues | 0.00 | 47.12 | 35.12 | 56.86 | 44.49 |
| Total Operating Revenues | 4648.10 | 4208.71 | 3742.64 | 3340.99 | 2889.69 |
| | | | | | |
| Other Income | 94.50 | 84.60 | 98.64 | 115.68 | 25.98 |
| Total Revenue | 4742.60 | 4293.31 | 3841.28 | 3456.67 | 2915.67 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 846.60 | 939.43 | 878.36 | 779.34 | 706.41 |
| Purchase Of Stock-In Trade | 249.80 | 166.35 | 146.28 | 136.10 | 89.54 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -25.64 | -39.21 | 25.76 | -83.17 | -150.90 |
| Employee Benefit Expenses | 1089.69 | 900.34 | 785.14 | 645.78 | 548.25 |
| Finance Costs | 20.73 | 7.21 | 5.84 | 10.20 | 8.27 |
| Depreciation And Amortisation Expenses | 144.11 | 135.40 | 130.80 | 125.30 | 116.09 |
| Other Expenses | 1228.15 | 1069.86 | 1123.85 | 933.64 | 697.83 |
| Total Expenses | 3553.44 | 3179.38 | 3096.03 | 2547.19 | 2015.49 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1189.16 | 1113.93 | 745.25 | 909.48 | 900.18 |
| | | | | | |
| Profit/Loss Before Tax | 1189.16 | 1113.93 | 745.25 | 909.48 | 900.18 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 268.77 | 298.22 | 175.58 | 217.22 | 269.74 |
| Deferred Tax | 0.00 | -24.30 | -39.97 | 4.94 | -15.05 |
| Tax For Earlier Years | 0.00 | 23.84 | 21.66 | -25.36 | -8.38 |
| Total Tax Expenses | 268.77 | 297.76 | 157.27 | 196.80 | 246.31 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 920.39 | 816.17 | 587.98 | 712.68 | 653.87 |
| | | | | | |
| Profit/Loss From Continuing Operations | 920.39 | 816.17 | 587.98 | 712.68 | 653.87 |
| | | | | | |
| Profit/Loss For The Period | 920.39 | 816.17 | 587.98 | 712.68 | 653.87 |
| Consolidated Profit/Loss After MI And Associates | 920.39 | 816.17 | 587.98 | 712.68 | 653.87 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 73.56 | 64.82 | 45.89 | 82.45 | 75.09 |
| Diluted EPS (Rs.) | 73.53 | 64.77 | 45.89 | 82.45 | 75.09 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 642.17 | 89.69 | 82.21 | 82.90 |
